Madia Lozupone

Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging

Vincenzo Solfrizzi, Emanuele Scafato, Davide Seripa et al. · Journal of the American Medical Directors Association · 2016 · 186 citations

Reversible Cognitive Frailty, All-cause Mortality, Aging +12

Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging

Vincenzo Solfrizzi, Emanuele Scafato, Madia Lozupone et al. · American Journal of Geriatric Psychiatry · 2017 · 128 citations

Additive Role, Alzheimer's Disease, Aging +13

Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy

Francesco Panza, Vincenzo Solfrizzi, Davide Seripa et al. · Immunotherapy · 2016 · 99 citations

Immunology, Neurochemical Biomarkers, Therapeutics +16

Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance

Alessandro Bertolino, Paolo Taurisano, N. Pisciotta et al. · PLoS ONE · 2010 · 93 citations · Full text

BACE inhibitors in clinical development for the treatment of Alzheimer’s disease

Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi et al. · Expert Review of Neurotherapeutics · 2018 · 87 citations

Neurochemical Biomarkers, Alzheimer ’, Pre-clinical Pharmacology +23